Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.07, 7.01, 9.01 · 8-K

TIC Solutions, Inc

TICNYSEEQUITYCurrent

Submission of Matters to a Vote of Security Holders · Regulation FD Disclosure

Item 5.07 Submission of Matters to a Vote of Security Holders. On July 31, 2025, Acuren Corporation (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the stockholders voted on the (i) approval of the issuance of shares of common stock, par value $0.0001 per share of the Company (the “Common Stock”), to stockholders of NV5 Global, Inc.…

Filed Jul 31, 2025Accepted Jul 31, 2025, 4:27 PM EDTCIK 2032966Accession 0001213900-25-070009
Share

Company context

Acuren is a leading provider of tech-enabled Testing, Inspection, Certification, and Compliance (TICC) services and critical asset integrity solutions. Operating primarily in North America, Acuren serves diversified end markets that are essential to the North American economy, including industrials, infrastructure, energy, midstream, and renewables. Acuren supports clients across the full asset lifecycle, from commissioning to compliance, powering its solutions with unique go-to-market methods including advanced inspection and nondestructive testing (NDT), Rope Access Technician (RAT) mitigation services, materials engineering services, lab analysis and destructive testing, proprietary software, and drone-enabled geospatial analytics. Acuren’s TICC services are mission-critical, frequently compliance-mandated, and typically recurring in nature.

Current securities

Historical securities (1)

Recent company filings

  1. Results of Operations and Financial ConditionNov 5, 2026
  2. 10-Q filingNov 5, 2026
  3. SCHEDULE 13G/A - filed by Gates Capital Management, Inc. regarding TIC Solutions, Inc.Aug 14, 2026
  4. 10-Q filingAug 6, 2026
  5. Results of Operations and Financial ConditionAug 6, 2026

Disclosure sections

Items 5.07, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders. On July 31, 2025, Acuren Corporation (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the stockholders voted on the (i) approval of the issuance of shares of common stock, par value $0.0001 per share of the Company (the “Common Stock”), to stockholders of NV5 Global, Inc. (“NV5”) in connection with the Agreement and Plan of Merger dated May 14, 2025, by and among the Company, NV5, and certain direct, wholly owned subsidiaries of the Company (Proposal 1), (ii) election of eight director nominees (Proposal 2), (iii) ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered accounting firm for the 2025 fiscal year (Proposal 3), and (iv) approval of the Company’s 2025 Employee Stock Purchase Plan (Proposal 4). The proposal to approve the adjournment of the Annual Meeting was not voted on at the Special Meeting because there were sufficient votes to approve Proposal 1. The results of the votes are set forth below. Proposal 1 - Approval of the Issuance of Shares of the Company to Stockholders of NV5 The stockholders approved the issuance of shares of Common Stock to stockholders of NV5 in connection with the Agreement and Plan of Merger. For Against Abstain ──────────────────────────────────────────────────────────────────────── 94,157,704 6,285 24,153 Proposal 2 - Election of Directors The stockholders voted in favor of the election of the following director nominees as directors for a term of office expiring at the Company’s 2026 Annual Meeting of Stockholders and, in each case, until his or her successor is duly elected and qualified. For Against Abstain ─────────────────────────────────────────────────────────────────────── Sir Martin E. Franklin 91,027,329 3,149,584 11,229 Robert A. E. Franklin 93,192,053 983,560 12,529 Antoinette C. Bush 94,074,314 78,105 35,723 Rory Cullinan 94,148,401 28,418 11,323 Elizabeth Meloy Hepding 94,094,716 57,668 35,758 Peter Hochfelder 94,138,229 38,290 11,623 James E. Lillie 90,173,481 4,003,337 11,324 Talman Pizzey 94,087,506 89,313 11,323 Proposal 3 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. For Against Abstain ───────────────────────────────────────────────────────────────────────── 94,155,216 21,803 11,123 Proposal 4 - Approval of the Company’s 2025 Employee Stock Purchase Plan The stockholders approved the 2025 Employee Stock Purchase Plan. For Against Abstain ───────────────────────────────────────────────────────────────────────── 94,139,694 34,925 13,523
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Acuren issued a press release on July 31, 2025, announcing the voting results of the Annual Meeting, which is furnished hereto as Exhibit 99.1 and incorporated into this Item 7.01 by reference.
Filed exhibits (1)
EX-99.1 (by filename) ea025106701ex99-1_acuren.htm

EX-99.1 2 ea025106701ex99-1_acuren.htm PRESS RELEASE, DATED JULY 31, 2025 Exhibit 99.1 Acuren Corporation Stockholders Approve Stock Issuance in Merger with NV5 Global, Inc. July 31, 2025 TOMBALL, Texas: Acuren Corporation (NYSE: TIC) (the “Company” or “Acuren”) announced today that its stockholders voted to approve the issuance of shares of Acuren common stock to stockholders of NV5 Global, Inc. (“NV5”), in connection with the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of May 14, 2025, by and among Acuren, NV5, Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc. (“Acuren Stock Issuance Proposal”). The vote occurred at Acuren’s annual meeting of stockholders (the “Meeting”) that was held on July 31, 2025, at 9:30 AM ET. Approval of the Acuren Stock Issuance Proposal required the affirmative vote of a majority of the votes cast at the Meeting. 99.99% of the votes cast at the Meeting voted in favor of the Acuren Stock Issuance Proposal. Tal Pizzey, Chief Executive Officer of Acuren, said, “We thank our stockholders for their support for the business combination with NV5, and with this milestone now complete, we look forward to mov…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.